Search Results - "Pereira, Sara G T"

  • Showing 1 - 4 results of 4
Refine Results
  1. 1
  2. 2

    Intracellular Activation of a Prostate Specific Antigen-Cleavable Doxorubicin Prodrug: A Key Feature Toward Prodrug-Nanomedicine Design by Pereira, Sara G. T, Hudoklin, Samo, Kreft, Mateja Erdani, Kostevsek, Nina, Stuart, Marc C. A, Al-Jamal, Wafa T

    Published in Molecular pharmaceutics (01-04-2019)
    “…L-377,202 prodrug (Dox-PSA) was in phase I clinical trials for patients with metastatic castration-resistant prostate cancer (mCRPC). It consists of…”
    Get full text
    Journal Article
  3. 3

    Genetically-engineered anti-PSMA exosome mimetics targeting advanced prostate cancer in vitro and in vivo by Severic, Maja, Ma, Guanglong, Pereira, Sara G T, Ruiz, Amalia, Cheung, Calvin C.L., Al-Jamal, Wafa T.

    Published in Journal of controlled release (10-02-2021)
    “…The present work describes the engineering of anti-PSMA peptide-decorated exosome mimetics (EMs) targeting advanced prostate cancer (PC). The targeted EMs were…”
    Get full text
    Journal Article
  4. 4

    Encapsulated doxorubicin crystals influence lysolipid temperature-sensitive liposomes release and therapeutic efficacy in vitro and in vivo by Ruiz, Amalia, Ma, Guanglong, Seitsonen, Jani, Pereira, Sara G.T., Ruokolainen, Janne, Al-Jamal, Wafa T.

    Published in Journal of controlled release (10-12-2020)
    “…Doxorubicin (DOX)-loaded lysolipid temperature-sensitive liposomes (LTSLs) are a promising stimuli-responsive drug delivery system that rapidly releases DOX in…”
    Get full text
    Journal Article